Marketers are the Christopher Columbus-es of the decade, always trying to reach unexplored territories. Female sexuality is the new New World.
From a rational standpoint, I must applaud Pfizer, the maker of Viagra, who is developing female sexual dysfunction drugs. Currently, it occupies the number one position in the erectile dysfunction drugs market.
Already has it won the battle for the consumer’s mind, the “bam-chicka-wow-wow” commercials and the little blue pills have become a part of popular culture. Pfizer can cement the public’s perception of their products and expanding into a new market with its female equivalent.
Worrisome news comes with the revelation that Pfizer has manipulated medical research on female sexuality and is helping to define the disorder. This seems to confirm the paranoia that has long dogged Big Pharma: they are inventing or promoting medical conditions to sell their products. I can’t help but be concerned about this trend of merging medical research and marketing.
Little pink pills? A savvy business move, but questionable morals.
Leave a Reply